A systematic assessment of VIP in experimental autoimmune encephalomyelitis (the MS model) found that VIP administration lessened scientific severity scores by forty–65% across twelve unbiased scientific tests, with histological Examination displaying diminished CNS infiltration of Th1 and Th17 cells and increased Foxp3+ Tregs within the spinal c